AI assistant
DEXCOM INC — Director's Dealing 2015
Mar 10, 2015
30198_dirs_2015-03-10_7d916749-3e2b-4342-a4ff-7c157efd4bd2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2015-03-08
Reporting Person: GREGG TERRANCE H (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-08 | Common Stock | A | 35000.0 | $0.0010 | Acquired | 430626 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 11461 | Indirect |
| Common Stock | 566389 | Indirect |
Footnotes
F1: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and subject to vesting in one annual installment from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
F2: Included in this number are 222,892 unvested restricted stock units, 35,000 of which were granted on March 8, 2015 and will vest on March 8, 2016, 121,876 unvested restricted stock units granted on March 8, 2014, 5,078 of which shall vest each month through March 8, 2017, and 66,016 unvested restricted stock units granted on March 11, 2013, 5,078 of which shall vest each month through March 11, 2016.
F3: Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.